Document is current
Any future updates will be listed below
-
Authors
Vestergaard, Thea https://orcid.org/0000-0002-5373-8661
Julsgaard, Mette
Helmig, Rikke Bek
Faunø, Emilie
Vendelboe, Tau
Kelsen, Jens
Laurberg, Trine Bay
Sørensen, Anne
Pedersen, Bodil Ginnerup
-
Funding
Funding for this research was provided by:
Sundhedsvidenskabelige Fakultet, Aarhus Universitet
Gigtforeningen
Colitis-Crohn Foreningen
Aage og Johanne Louis-Hansens Fond
Aase og Ejnar Danielsens Fond
Fonden til Lægevidenskabens Fremme
Aarhus University Hospital
- License Information
-
More Information
Article History
Received: 27 September 2023
Revised: 23 January 2024
Accepted: 24 January 2024
First Online: 26 April 2024
Declarations
:
: M. Julsgaard has received research grants for other investigator-driven studies from Takeda, and the NOVO Nordisk Foundation (grant no. NNF23OC0081717), has received consultation fee from Ferring and Takeda and has received speaker’s fees from Tillotts Pharma, MSD, Ferring, and Takeda. Jens Kelsen has served on the advisory board of Gilead, Takeda and Janssen and has received speaker’s fee from Pfizer. The remaining authors disclose no conflicts.
